ASCO: Conjugated Equine Estrogen May Increase Risk for Ovarian Cancer
However, conjugated equine estrogen plus medroxyprogesterone acetate does not increase this risk and may cut risk for developing uterine cancer.
Source: empr.com
Rowant Chlebowski News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Rowant Chlebowski. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Rowant Chlebowski Today - Breaking & Trending Today
Conjugated equine estrogen may increase risk for ovarian cancer
Conjugated equine estrogen (CEE) taken alone for menopause may increase the risk for developing and dying from ovarian cancer, according to a study presented at the annual meeting of the American Society of Clinical Oncology, held from May 31 to June 4 in Chicago.
Source: medicalxpress.com
How Metabolic Syndrome, Obesity Impact Breast Cancer Risk
New data from the Women's Health Initiative revealed that metabolic syndrome and obesity each have different associations with breast cancer incidence and mortality risk in postmenopausal women.
Source: medscape.com
Long-Term Findings Clarify Role of Estrogen Therapy on Ovarian/Endometrial Cancer Incidence
Treatment with CEE alone was associated with increased ovarian cancer incidence and mortality rates in postmenopausal women who had undergone hysterectomy.
Source: onclive.com
Metabolic Syndrome, Obesity Independently Linked to Breast Cancer
Analyses show independent and distinct associations with breast cancer subtypes and mortality. Analyses show independent and distinct associations with breast cancer subtypes and mortality.
Source: oncologynurseadvisor.com